| 000 | 01875 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515173129.0 | ||
| 264 | 0 | _c20091008 | |
| 008 | 200910s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 024 | 7 |
_a10.3899/jrheum.081207 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aStoch, S Aubrey | |
| 245 | 0 | 0 |
_aOnce-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cAug 2009 |
||
| 300 |
_a1705-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAlendronate _xadministration & dosage |
| 650 | 0 | 4 |
_aBiomarkers _xmetabolism |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aCalcium _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xadverse effects |
| 650 | 0 | 4 |
_aHip Joint _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLumbar Vertebrae _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xchemically induced |
| 650 | 0 | 4 | _aPlacebos |
| 650 | 0 | 4 |
_aRheumatic Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aVitamin D _xadministration & dosage |
| 700 | 1 | _aSaag, Kenneth G | |
| 700 | 1 | _aGreenwald, Maria | |
| 700 | 1 | _aSebba, Anthony I | |
| 700 | 1 | _aCohen, Stanley | |
| 700 | 1 | _aVerbruggen, Nadia | |
| 700 | 1 | _aGiezek, Hilde | |
| 700 | 1 | _aWest, Joseph | |
| 700 | 1 | _aSchnitzer, Thomas J | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 36 _gno. 8 _gp. 1705-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.081207 _zAvailable from publisher's website |
| 999 |
_c18912073 _d18912073 |
||